<p>Validation and Comparison of a Modified Elixhauser Index for Predicting In-Hospital Mortality in Italian Internal Medicine Wards</p>

Abstract

Burden of comorbidities appears to be related to clinical outcomes in hospitalized patients. Clinical stratification of admitted patients could be obtained calculating a comorbidity score, which represents the simplest way to identify the severity of patients' clinical conditions and a practical approach to assess prevalent comorbidities. Our aim was to validate a modified Elixhauser score for predicting in-hospital mortality (IHM) in internal medicine admissions and to compare it with a different one derived from clinical data previously used in a similar setting, having a good prognostic accuracy. Patients and Methods: A single-center retrospective study enrolled all patients admitted to internal medicine department between January and June 2016. A modified Elixhauser score was calculated from chart review and administrative data; moreover, a second prognostic index was calculated from chart review only. Comorbidity scores were compared using c-statistic. Results: We analyzed 1614 individuals without selecting the reason for admission, 224 (13.9%) died during hospital stay. Deceased subjects were older (83.3±9.1 vs 78.4±13.5 years; p<0.001) and had higher burden of comorbidities. The modified Elixhauser score calculated by administrative data and by chart review and the comparator one was 18.13 ±9.36 vs 24.43±11.27 vs 7.63±3.3, respectively, and the c-statistic was 0.758 (95% CI 0.727-0.790), 0.811 (95% CI 0.782-0.840) and 0.740 (95% CI 0.709-0.771), respectively. Conclusion: The new modified Elixhauser score showed a similar performance to a previous clinical prognostic index when it was calculated using administrative data; however, its performance improved if calculation was based on chart review.

Is venous thromboembolism a predictable marker in older patients with COVID-19 infection? A single-center observational study

“…Patients were assessed by means of the Padua Prediction Score [22], representing the main clinical score able to assess the risk of thrombotic events, by the Modified Early Warning Scoring (MEWS) [23], a promising performance score able to predict in-hospital mortality [24], and by the modified Elixhauser index (mEI) [25][26], a comorbidity score associated with inhospital mortality in Internal Medicine. All patients underwent venous color-doppler ultrasound of the lower limbs in order to identify the presence of DVT.…”

Do Sex-Related Differences of Comorbidity Burden and/or In-Hospital Mortality Exist in Cancer Patients? A Retrospective Study in an Internal Medicine Setting

“…The use of the Charlson Comorbidity Index, a score validated in internal medicine settings [ 17 ], has been shown to improve accuracy [ 18 , 19 ]. We used a modified version of the Elixhauser Index, proposed by our group, validated for patients admitted to internal medicine wards [ 12 , 20 ], and also positively tested as a valid predictor of IHM in other diverse conditions. [ 21 , 22 ], which was integrated for this study with specific adjustments for hematologic, solid cancer, and metastasis (mEI-Ad).…”

Seasonal pattern in elderly hospitalized with acute kidney injury: a retrospective nationwide study in Italy

“…We evaluated IHM related to the season of hospitalization. We also evaluated the comorbidity burden, using a modified Elixhauser Index (mEI) [ 22 , 23 ]. It was calculated based on the guidelines set by Quan et al [ 24 ].…”